Segall Bryant & Hamill, LLC Horizon Therapeutics Public LTD CO Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $13.6 Million - $14.4 Million	-126,746 Reduced 97.09%	3,798 $414,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $8.14 Million - $14.9 Million	130,544 New	130,544 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $10.7 Million - $15.4 Million	181,693 New	181,693 $11.2 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.99 Million - $2.92 Million	-25,094 Reduced 15.42%	137,621 $11 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2.66 Million - $3.39 Million	30,834 Added 23.38%	162,715 $17.1 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $396,605 - $482,517	-4,024 Reduced 2.96%	131,881 $14.2 Million
Q3 2021 Nov 03, 2021	SELL	$91.91 - $110.37 $1.45 Million - $1.75 Million	-15,811 Reduced 10.42%	135,905 $14.9 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $1.31 Million - $1.45 Million	15,165 Added 11.11%	151,716 $14.2 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $2.35 Million - $3.13 Million	-32,763 Reduced 19.35%	136,551 $12.6 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $612,112 - $770,987	9,136 Added 5.7%	169,314 $12.4 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $2.07 Million - $2.99 Million	37,432 Added 30.5%	160,178 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $631,300 - $1.19 Million	-20,904 Reduced 14.55%	122,746 $6.82 Million
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $330,671 - $512,693	13,296 Added 10.2%	143,650 $4.25 Million
Q4 2019 Feb 11, 2020	SELL	$25.43 - $36.67 $161,404 - $232,744	-6,347 Reduced 4.64%	130,354 $4.72 Million
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $509,887 - $620,066	-22,169 Reduced 13.95%	136,701 $3.72 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $168,543 - $210,438	7,389 Added 4.88%	158,870 $0
Q1 2019 May 15, 2019	BUY	$19.49 - $29.01 $2.95 Million - $4.39 Million	151,481 New	151,481 $0

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account